ESTRO、ESNR与EORTC发布颅内CNS肿瘤放疗后MRI异常共识定义
针对颅内CNS肿瘤放疗后MRI异常术语与定义异质性问题,RING组织国际多学科德尔菲共识,经三轮问卷(共识阈值≥75%同意)确立治疗相关影像异常(TRIA)术语及潜在与确认TRIA定义,并获得ESTRO、ESNR和EORTC认可。该框架旨在统一报告、支持临床决策并提升研究可比性。
要点
- 采用「治疗相关影像异常(TRIA)」统一描述放疗后MRI异常。
- 共识明确潜在TRIA与确认TRIA的定义及基于影像特征亚分类。
- 共识识别MRI申请单最低必填要素以规范框架应用。
核心结论
- 该德尔菲共识为颅内CNS肿瘤放疗后MRI异常提供标准化定义框架,旨在统一报告、支持临床决策并改善未来神经肿瘤研究的可比性。
研究设计与样本
- 在放射影像与神经肿瘤学组(RING)内开展国际多学科德尔菲共识,由指导委员会制定问卷并发放给放射肿瘤学、神经放射学、神经肿瘤学、医学肿瘤学和神经外科专家,采用三轮德尔菲法,共识定义为≥75%同意。
主要发现
- 共识就术语适用性与定义达成一致,采用治疗相关影像异常(TRIA)这一术语。
- 共识建立了潜在TRIA与确认TRIA的明确定义。
- 基于影像特征的亚分类均显示高度同意。
- 共识识别了MRI申请单的最低必填要素,以保障框架的一致应用。
- 最终共识获得ESTRO、ESNR和EORTC认可。
关键数值与推荐
- 共识阈值定义为≥75%同意。
- 采用术语为治疗相关影像异常(TRIA)。
- 建立潜在TRIA与确认TRIA的明确定义。
- 基于影像特征的亚分类均显示高度同意。
- 识别MRI申请单的最低必填要素。
临床怎么用
- 临床可采用TRIA术语及潜在/确认TRIA定义规范描述颅内CNS肿瘤放疗后MRI异常。
- 可依据影像特征亚分类对TRIA进行归类报告。
- MRI申请单应包含共识识别的最低必填要素以保障框架一致应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Magnetic resonance imaging (MRI) is essential for post-treatment surveillance of patients with intracranial central nervous system (CNS) tumours. However, interpretation is often complicated due to post radiotherapy MRI abnormalities. Current literature demonstrates substantial heterogeneity in terminology and definitions used to describe these MRI abnormalities, limiting clinical decision-making and comparability across studies. To address this, an international multidisciplinary Delphi consensus was conducted within the Radiation Imaging and Neuro-Oncology Group (RING). Questionnaires were developed by the steering committee and distributed to experts in radiation oncology, neuroradiology, neuro-oncology, medical oncology, and neurosurgery. A three-round Delphi method was employed, with consensus defined as ≥ 75% agreement. Consensus was reached on the applicability and definitions with adoption of the term Treatment-Related Imaging Abnormality (TRIA). Clear definitions for potential and confirmed TRIA were established. Subcategorization based on imaging features all demonstrated high agreement. For consistent application of the framework minimal essential elements for MRI request forms were identified. The final consensus was endorsed by ESTRO, ESNR and EORTC. This Delphi consensus provides a standardized framework for MRI abnormalities following radiotherapy for intracranial CNS tumours. The framework aims to harmonize reporting, support clinical decision-making, and improve comparability in future neuro-oncology research. Central nervous system neoplasms - Radiotherapy - Magnetic resonance imaging - Delphi Technique - Treatment-Related Imaging Abnormality (TRIA). After radiotherapy for brain tumours changes can appear on follow-up MRI scans. These changes may represent treatment reactions, clinically relevant complications or tumour-related growth and distinguishing between them can be challenging. Many terms and definitions are currently used to describe these reactions, which complicates communication, clinical decision-making and research. This project brought together international experts in brain tumour treatment to agree on a standardised set of definitions. Using structured online surveys, the panel reached consensus on a concept called Treatment-Related Imaging Abnormality (TRIA). This standardised approach should improve clinical practice, support clearer communication, and enhance research in this field.
引用
- Lauwens L, Zegers CML, Postma AA, et al. ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumours. Neuro Oncol. 2026. PMID: 42623110. doi:10.1093/neuonc/noag194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。